Stock DZ
12.07.2018 kl 09:51
1271

Thanks Flottesen ...

Thats probably why i think the reason of low fimavacc doses is linked to this. by low doses may be there will be less holes in the cellular barriers thus less damage and more cells will contribute to the immune response. so this "issue" if it exists, is more linked to efficacy than to safety.

this is only an opinion :)
Arkivert